home / stock / nvo / nvo articles

NVO Articles, Novo Nordisk A/S - From 07/12/24

Stock Information
Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Website: novonordisk.com
Menu
NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...
Using Ozempic, Zepbound Or Other Weight Loss Drugs? Inform Doctors Before Anesthesia Or Surgery, European Medicines Agency Issues Advisory | Benzinga

On Friday, the European Medicines Agency (EMA) warned patients using weight-loss drugs, such as Novo Nordisk A/S’s (NYSE:NVO) Wegovy, to info...
Novo Nordisk's 'Miracle' Weight Loss Drug Ozempic Linked To 48% Lower Risk Of Dementia, Study Finds | Benzinga

Novo Nordisk A/S. (NYSE:NVO) has found that its “miracle” weight loss drug used for diabetes, Ozempic, is linked to a significant reduc...

Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition | Benzinga

Shares of Eli Lilly and Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) finished lower on Thursday, perhaps influenced by competitive developments an...

Bernie Sanders Targets High Prices of Ozempic and Wegovy In US | Benzinga

Senator Bernie Sanders expressed confidence that Novo Nordisk A/S (NYSE:NVO) can be persuaded to reduce the U.S. prices of its popular weight-loss ...
FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes | Benzinga

On Wednesday, the FDA issued a Complete Response Letter (CRL) related to Novo Nordisk A/S’s (NYSE:NVO) Biologics License Application for once...

EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year | Benzinga

Vivani Medical Inc. (NASDAQ:VANI) expects to initiate the first clinical study for the NPM-115 program in Australia in the fourth quarter of 2024. ...

Jim Cramer Identifies Eight Companies Eyeing Trillion-Dollar Club — Elon Musk's Tesla, Eli Lilly Top Contenders | Benzinga

Jim Cramer has identified eight companies that could potentially reach a market cap of $1 trillion, joining tech giants Microsoft Corp. (NASDAQ:MSF...
Only 25% Patients Stick With Novo Nordisk's Wegovy Or Ozempic After 2 Years, A Study Shows; Company Calls Data Insufficient | Benzinga

An analysis of U.S. pharmacy claims data reveals that only one in four patients prescribed Novo Nordisk A/S’s (NYSE:NVO) weight-loss drugs, W...

Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows | Benzinga

Eli Lilly and Co. (NYSE:LLY) has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’...

GLP-1 Treatments Such As Wegvoy, Mounjaro Cut Obesity-Related Cancer Risks, Study Finds | Benzinga

In a study published in JAMA Network, patients with type 2 diabetes taking GLP-1 treatments have a reduced risk of developing ten types of obesity-...
Previous 10 Next 10